Page last updated: 2024-12-11

flavokawain b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

flavokawain B: from Piper methysticum Forst (Kava Kava) roots; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

flavokawain B : A member of the class of chalcones that consists of trans-chalcone substituted by hydroxy group at positions 2' and methoxy groups at positions 4' and 6'. Isolated from Piper methysticum and Piper rusbyi, it exhibits antileishmanial, anti-inflammatory and antineoplastic activities. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
PipergenusA plant genus of the family PIPERACEAE that includes species used for spicy and stimulating qualities.[MeSH]PiperaceaeA family of flowering plants in the order Piperales best known for the black pepper widely used in SPICES, and for KAVA and Betel used for neuroactive properties.[MeSH]
Piper rusbyispecies[no description available]PiperaceaeA family of flowering plants in the order Piperales best known for the black pepper widely used in SPICES, and for KAVA and Betel used for neuroactive properties.[MeSH]
Piper methysticumspecies[no description available]PiperaceaeA family of flowering plants in the order Piperales best known for the black pepper widely used in SPICES, and for KAVA and Betel used for neuroactive properties.[MeSH]

Cross-References

ID SourceID
PubMed CID5356121
CHEMBL ID104255
CHEBI ID65899
CHEBI ID92523
SCHEMBL ID1675987
MeSH IDM0420789

Synonyms (55)

Synonym
flavokawain b
BRD-K30296925-001-02-1
BSPBIO_001873
76554-24-0
chalcone,6-dimethyl
nsc-51351
nsc51351
mls000737282 ,
SPECTRUM5_000188
MEGXP0_001270
2'-hydroxy-4',6'-dimethoxychalcone
smr000528248
chalcone,2-hydroxy-4,6-dimethyl
NCGC00095512-01
SPECTRUM201610
NCGC00095512-02
LMPK12120246
flavokawin b
chebi:65899 ,
CHEMBL104255
(e)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenylprop-2-en-1-one
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenylprop-2-en-1-one
A812279
1775-97-9
HMS2267O16
unii-r9wc6sm4uq
4',6'-dimethoxy-2'-hydroxychalcone
2-propen-1-one, 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenyl-, (e)-
r9wc6sm4uq ,
1175-97-9
S9412
CCG-38384
(2e)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenylprop-2-en-1-one
flavokavain b
SCHEMBL1675987
chalcone, 2'-hydroxy-4',6'-dimethoxy-
2-propen-1-one, 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenyl-, (2e)-
flavokavin b
QKQLSQLKXBHUSO-CMDGGOBGSA-N
(e)-2'-hydroxy-4',6'-dimethoxychalcone
AC-34272
mfcd00075877
SR-01000777225-3
sr-01000777225
AKOS027383422
CHEBI:92523
J-011297
HY-N2132
Q5458167
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenyl-2-propen-1-one
bdbm50491168
(2e)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenyl-2-propen-1-one
persicochalcone
CS-0018683
DTXSID601028794

Research Excerpts

Overview

Flavokawain B (FKB) is a naturally occurring chalcone molecule capable of providing effective therapy against this life-threatening disease. It can be found in the roots of the kava-kava plant.

ExcerptReferenceRelevance
"Flavokawain B (FKB) is a naturally occurring chalcone molecule capable of providing effective therapy against this life-threatening disease."( Cytotoxic Flavokawain B Inhibits the Growth and Metastasis of Hepatocellular Carcinoma through
Adamu, AA; Alhassan, AM; Bello, MB; Imam, MU; Malami, I; Muhammad, A, 2023
)
2.03
"Flavokawain B (FKB), is a natural chalcone isolated from kava root that induces apoptosis in cancer cells. "( The Combination of Flavokawain B and Daunorubicin Induces Apoptosis in Human Myeloid Leukemic Cells by Modifying NF-κB.
Im, HJ; Jang, S; Kim, N; Koh, KN; Lee, JJ; Park, CJ, 2018
)
2.25
"Flavokawain B (FKB) is a naturally occurring chalcone that can be isolated through the root extracts of the kava-kava plant (Piper methysticum). "( In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.
Abdullah, MP; Abu, N; Akhtar, MN; Alitheen, NB; Kee, BB; Lim, KL; Mohamed, NE; Omar, AR; Yeap, SK; Zulfadli, AJ, 2015
)
2.12
"Flavokawain B is a unique chalcone, which can be found in the roots of the kava-kava plant."( Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro.
Abdullah, MP; Abu, N; Akhtar, MN; Alitheen, NB; Ho, CL; Ho, WY; Ismail, J; Lim, KL; Omar, AR; Yeap, SK, 2016
)
2.6
"Flavokawain B is a natural chalcone isolated from the rhizomes of Alpenia pricei Hayata. "( Flavokawain B inhibits growth of human squamous carcinoma cells: Involvement of apoptosis and cell cycle dysregulation in vitro and in vivo.
Chang, HW; Chen, CS; Chen, SC; Hseu, YC; Liao, JW; Lin, E; Lin, KY; Lin, WH; Wang, L; Wang, SY; Yang, HL, 2012
)
3.26

Effects

ExcerptReferenceRelevance
"Flavokawain B (FKB) has been identified from kava root extracts as a potent apoptosis inducer for inhibiting the growth of various cancer cell lines, including prostate cancer. "( Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.
Fu, D; Hoang, BH; Li, X; Pham, V; Rendon, R; Song, L; Tippin, M; Uchio, E; Zi, X, 2019
)
3.4

Toxicity

ExcerptReferenceRelevance
" This adverse potential has never been captured in animal models, and the responsible compound(s) remains to be determined."( Flavokawains a and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice.
Leitzman, P; Narayanapillai, SC; O'Sullivan, MG; Xing, C, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antileishmanial agentAn antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
chalconesA ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.
dimethoxybenzeneAny methoxybenzene that consists of a benzene skeleton substituted with two methoxy groups and its derivatives.
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (47)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency25.11890.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency25.11890.025120.237639.8107AID893
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency31.62280.631035.7641100.0000AID504339
LuciferasePhotinus pyralis (common eastern firefly)Potency10.69100.007215.758889.3584AID588342
glp-1 receptor, partialHomo sapiens (human)Potency25.11890.01846.806014.1254AID624417
ATAD5 protein, partialHomo sapiens (human)Potency20.58780.004110.890331.5287AID504467
USP1 protein, partialHomo sapiens (human)Potency56.23410.031637.5844354.8130AID504865
TDP1 proteinHomo sapiens (human)Potency21.98980.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency12.06270.180013.557439.8107AID1460
Smad3Homo sapiens (human)Potency28.18380.00527.809829.0929AID588855
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency14.12540.707912.194339.8107AID720542
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency11.22020.28189.721235.4813AID2326
67.9K proteinVaccinia virusPotency15.39890.00018.4406100.0000AID720579; AID720580
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency14.12540.707936.904389.1251AID504333
P53Homo sapiens (human)Potency22.38720.07319.685831.6228AID504706
IDH1Homo sapiens (human)Potency29.09290.005210.865235.4813AID686970
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency16.19360.016525.307841.3999AID602332
serine-protein kinase ATM isoform aHomo sapiens (human)Potency28.18380.707925.111941.2351AID485349
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency31.62280.316212.443531.6228AID902
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency38.61050.354828.065989.1251AID504847
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency50.11873.548119.542744.6684AID743266
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency17.78280.010323.856763.0957AID2662
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency8.91250.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency8.91250.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency8.91250.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency24.80330.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency29.09290.004611.374133.4983AID624296; AID624297
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency15.84890.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Guanine nucleotide-binding protein GHomo sapiens (human)Potency19.95261.995325.532750.1187AID624288
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency15.84891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Urease subunit alphaHelicobacter pylori 26695IC50 (µMol)1,220.00000.29003.87606.7000AID745311
Urease subunit betaHelicobacter pylori 26695IC50 (µMol)1,220.00000.29003.87606.7000AID745311
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (127)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1427292Induction of apoptosis in human MDA-MB-231 cells harboring p53 mutant assessed as increase in cleaved caspase3 at 2 times IC50 after 24 hrs by Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427275Selectivity index, ratio of IC50 for human fibroblasts to IC50 for human MDA-MB-231 cells2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427265Cytotoxicity against human MDA-MB-231 cells assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427293Cell cycle arrest in human HuH7 cells assessed as mitotic index at 10 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.2 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427290Induction of apoptosis in human HCT116 cells harboring wild-type p53 assessed as increase in cleaved caspase3 at 2 times IC50 after 48 hrs by Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1737238Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay2020European journal of medicinal chemistry, May-01, Volume: 193Development of a novel nitric oxide (NO) production inhibitor with potential therapeutic effect on chronic inflammation.
AID1698501Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control2020Journal of natural products, 10-23, Volume: 83, Issue:10
Biological Evaluation of Selected Flavonoids as Inhibitors of MNKs Targeting Acute Myeloid Leukemia.
AID1427296Cell cycle arrest in human Caco2 cells assessed as accumulation at S phase at 10 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 52.4%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID361394Induction of NADPH:quinone reductase activity in mouse Hepa-1c1c7 cells assessed as drug level required to double specific enzyme activity after 48 hrs by MTT assay2002Journal of natural products, Nov, Volume: 65, Issue:11
Activity-guided isolation of constituents of Renealmia nicolaioides with the potential to induce the phase II enzyme quinone reductase.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1427257Cytotoxicity against human MDA-MB-231 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427288Induction of apoptosis in human MCF7 cells harboring wild-type p53 assessed as increase in early apoptosis at 2 times IC50 after 24 hrs by YoPro/propidium iodide/Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427320Cell cycle arrest in human HaCaT cells harboring wild-type p53 assessed as accumulation at S phase at 25 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 52.3%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427262Cytotoxicity against human fibroblasts assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427334Cell cycle arrest in human HCT116 cells assessed as accumulation at G1/S phase by Hoechst staining based fluorescence assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1537670Cytotoxicity against human U937 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID1737236Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells at 10 uM measured after 24 hrs by Griess reagent based assay relative to control2020European journal of medicinal chemistry, May-01, Volume: 193Development of a novel nitric oxide (NO) production inhibitor with potential therapeutic effect on chronic inflammation.
AID1427258Cytotoxicity against human HCT116 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID669499Inhibition of ABCG2-mediated mitoxantrone efflux expressed in HEK293 cells at 2 uM after 48 hrs by flow cytometric analysis2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.
AID1427295Cell cycle arrest in human Caco2 cells assessed as mitotic index at 10 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 3.6 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427298Cell cycle arrest in human MDA-MB-231 cells harboring p53 mutant assessed as accumulation at S phase at 10 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 42.2%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID669500Inhibition of ABCG2-mediated mitoxantrone efflux expressed in HEK293 cells at 10 uM after 48 hrs by flow cytometric analysis2012Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7
Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.
AID1427301Cell cycle arrest in human PC3 cells harboring p53 mutant assessed as mitotic index at 10 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.5 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427269Cytotoxicity against human HaCaT cells assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427280Selectivity index, ratio of IC50 for human fibroblasts to IC50 for human RL cells2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1431556Lipophilicity, log P of the compound2017European journal of medicinal chemistry, Jan-27, Volume: 126Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds.
AID1427308Cell cycle arrest in human HuH7 cells assessed as accumulation at S phase at 25 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 44%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427286Induction of apoptosis in human MDA-MB-231 cells harboring p53 mutant assessed as increase in early apoptosis at 2 times IC50 after 24 hrs by YoPro/propidium iodide/Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID447716Hepatotoxicity against mouse Hepa-1c1c7 cells after 48 hrs by celltiter blue assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1427328Cell cycle arrest in human HuH7 cells assessed as accumulation at G1/S phase by Hoechst staining based fluorescence assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID447711Inhibition of TNF-alpha-induced NF-kappaB expressed in human A549 cells treated 1 hr after TNFalpha challenge measured after 6 hrs by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.
AID1427294Cell cycle arrest in human HuH7 cells assessed as accumulation at S phase at 10 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 44%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427263Cytotoxicity against human HuH7 cells assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427272Cytotoxicity against human MCF7 assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427268Cytotoxicity against human NCI-H727 cells assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427287Induction of apoptosis in human MDA-MB-231 cells harboring p53 mutant assessed as increase in late apoptosis at 2 times IC50 after 24 hrs by YoPro/propidium iodide/Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427291Induction of apoptosis in human PC3 cells harboring p53 mutant assessed as increase in cleaved caspase3 at 2 times IC50 after 48 hrs by Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427307Cell cycle arrest in human HuH7 cells assessed as mitotic index at 25 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.2 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427306Cell cycle arrest in human HaCaT cells harboring wild-type p53 assessed as accumulation at S phase at 10 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 52.3%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427302Cell cycle arrest in human PC3 cells harboring p53 mutant assessed as accumulation at S phase at 10 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 40.8%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1190839Antimelanogenic activity in mouse B16F10 cells assessed as inhibition of melanin production after 4 days2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Flavokawains B and C, melanogenesis inhibitors, isolated from the root of Piper methysticum and synthesis of analogs.
AID1427314Cell cycle arrest in human HCT116 cells harboring wild-type p53 assessed as accumulation at S phase at 25 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 68.4%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427340Cell cycle arrest in human HaCaT cells assessed as accumulation at G1/S phase by Hoechst staining based fluorescence assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427283Induction of apoptosis in human HCT116 cells harboring wild-type p53 assessed as increase in late apoptosis at 2 times IC50 after 48 hrs by YoPro/propidium iodide/Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427261Cytotoxicity against human HaCaT cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427337Cell cycle arrest in human PC3 cells assessed as accumulation at G1/S phase by Hoechst staining based fluorescence assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427313Cell cycle arrest in human HCT116 cells harboring wild-type p53 assessed as mitotic index at 25 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.3 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427260Cytotoxicity against human NCI-H727 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1431557Anti-parasitic activity against Trypanosoma brucei 4272017European journal of medicinal chemistry, Jan-27, Volume: 126Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds.
AID1537674Cytotoxicity against human HCT116 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID1427345Induction of apoptosis in human MCF7 cells harboring wild-type p53 assessed as upregulation of cyclinB1 measured after 18 hrs by Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427259Cytotoxicity against human PC3 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1737237Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells measured after 24 hrs by Griess reagent based assay2020European journal of medicinal chemistry, May-01, Volume: 193Development of a novel nitric oxide (NO) production inhibitor with potential therapeutic effect on chronic inflammation.
AID1427300Cell cycle arrest in human HCT116 cells harboring wild-type p53 assessed as accumulation at S phase at 10 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 68.4%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1427342Induction of apoptosis in human HCT116 cells harboring wild-type p53 assessed as upregulation of p21 measured after 48 hrs by Hoechst staining based fluorescence assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID659235Increase in intracellular GSH level in human MCF7 cells expressing antioxidant response element at 10 uM after 6 hrs by HPLC analysis relative to control2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
A synthetic chalcone as a potent inducer of glutathione biosynthesis.
AID1427271Cytotoxicity against human RL assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID659236Increase in intracellular GSH level in human MCF7 cells expressing antioxidant response element at 10 uM after 24 hrs by HPLC analysis relative to control2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
A synthetic chalcone as a potent inducer of glutathione biosynthesis.
AID1537669Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID1427284Induction of apoptosis in human PC3 cells harboring p53 mutant assessed as increase in early apoptosis at 2 times IC50 after 48 hrs by YoPro/propidium iodide/Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427309Cell cycle arrest in human Caco2 cells assessed as mitotic index at 25 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 3.6 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427305Cell cycle arrest in human HaCaT cells harboring wild-type p53 assessed as mitotic index at 10 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.6 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427310Cell cycle arrest in human Caco2 cells assessed as accumulation at S phase at 25 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 52.4%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427264Cytotoxicity against human Caco2 cells assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427279Selectivity index, ratio of IC50 for human fibroblasts to IC50 for human HaCaT cells2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427315Cell cycle arrest in human PC3 cells harboring p53 mutant assessed as mitotic index at 25 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.5 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427266Cytotoxicity against human HCT116 cells assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427289Induction of apoptosis in human MCF7 cells harboring wild-type p53 assessed as increase in late apoptosis at 2 times IC50 after 24 hrs by YoPro/propidium iodide/Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427343Induction of apoptosis in human MCF7 cells harboring wild-type p53 assessed as upregulation of p21 measured after 48 hrs by Hoechst staining based fluorescence assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1427297Cell cycle arrest in human MDA-MB-231 cells harboring p53 mutant assessed as mitotic index at 10 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.1 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427299Cell cycle arrest in human HCT116 cells harboring wild-type p53 assessed as mitotic index at 10 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.3 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427332Cell cycle arrest in human MDA-MB-231 cells assessed as accumulation at M phase by Hoechst staining based fluorescence assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427317Cell cycle arrest in human NCI-H727 cells harboring p53 mutant assessed as mitotic index at 25 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 1.1 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1188431Anticancer activity against human HSC3 cells2014European journal of medicinal chemistry, Oct-06, Volume: 85Recent developments in biological activities of chalcones: a mini review.
AID551964Cytotoxicity against mouse NIH/3T3 cells assessed as cell viability after 8 hrs2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies.
AID1427276Selectivity index, ratio of IC50 for human fibroblasts to IC50 for human HCT116 cells2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID329735Cell cycle arrest in human K562 cells assessed as accumulation at G2/M phase at 10 uM after 24 hrs by flow cytometry2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
AID1427255Cytotoxicity against human HuH7 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427338Cell cycle arrest in human NCI-H727 cells assessed as accumulation at G1/S phase by Hoechst staining based fluorescence assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427274Selectivity index, ratio of IC50 for human fibroblasts to IC50 for human Caco2 cells2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427277Selectivity index, ratio of IC50 for human fibroblasts to IC50 for human PC3 cells2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427311Cell cycle arrest in human MDA-MB-231 cells harboring p53 mutant assessed as mitotic index at 25 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.1 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427331Cell cycle arrest in human Caco2 cells assessed as accumulation at M phase by Hoechst staining based fluorescence assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427278Selectivity index, ratio of IC50 for human fibroblasts to IC50 for human NCI-H727 cells2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427346Induction of apoptosis in human PC3 cells harboring p53 mutant assessed as upregulation of cyclinB1 after 48 hrs by Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1427281Selectivity index, ratio of IC50 for human fibroblasts to IC50 for human MCF7 cells2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427303Cell cycle arrest in human NCI-H727 cells harboring p53 mutant assessed as mitotic index at 10 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 1.1 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427285Induction of apoptosis in human PC3 cells harboring p53 mutant assessed as increase in late apoptosis at 2 times IC50 after 48 hrs by YoPro/propidium iodide/Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427312Cell cycle arrest in human MDA-MB-231 cells harboring p53 mutant assessed as accumulation at S phase at 25 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 42.2%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427319Cell cycle arrest in human HaCaT cells harboring wild-type p53 assessed as mitotic index at 25 uM measured after 48 hrs by Hoechst staining based fluorescence assay (Rvb = 2.6 No_unit)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427304Cell cycle arrest in human NCI-H727 cells harboring p53 mutant assessed as accumulation at S phase at 10 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 40.3%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1537671Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID551962Inhibition of cobalt chloride-induced HIF-1 activation expressed in mouse NIH3T3 cells after 8 hrs by luciferase reporter gene assay2011Bioorganic & medicinal chemistry letters, Jan-01, Volume: 21, Issue:1
Chalcone-based inhibitors against hypoxia-inducible factor 1--structure activity relationship studies.
AID1427318Cell cycle arrest in human NCI-H727 cells harboring p53 mutant assessed as accumulation at S phase at 25 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 40.3%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID443496Inhibition of TNFalpha induced NF-kappaB activation in human A549 cells by luciferase reporter gene assay2009Journal of medicinal chemistry, Nov-26, Volume: 52, Issue:22
Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities.
AID1190838Inhibition of mushroom tyrosinase using L-tyrosine as substrate after 20 mins by microplate reader2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Flavokawains B and C, melanogenesis inhibitors, isolated from the root of Piper methysticum and synthesis of analogs.
AID1427267Cytotoxicity against human PC3 cells assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID102612The compound was tested for antiproliferative activity against MCF-7 human breast cancer cells2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Flavonoids: structural requirements for antiproliferative activity on breast cancer cells.
AID745311Inhibition of Helicobacter pylori ATCC 43504 urease-mediated ammonia production preincubated for 1.5 hrs by indophenol method2013European journal of medicinal chemistry, May, Volume: 63Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
AID1427270Cytotoxicity against human fibroblasts assessed as cell viability after 48 hrs by Hoechst 33342 staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427347Induction of apoptosis in human MDA-MB-231 cells harboring p53 mutant assessed as upregulation of cyclinB1 after 18 hrs by Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427316Cell cycle arrest in human PC3 cells harboring p53 mutant assessed as accumulation at S phase at 25 uM measured after 48 hrs by Hoechst/BrdU staining based fluorescence assay (Rvb = 40.8%)2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1537672Cytotoxicity against human MIAPaCa2 cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID1427273Selectivity index, ratio of IC50 for human fibroblasts to IC50 for human HuH7 cells2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427282Induction of apoptosis in human HCT116 cells harboring wild-type p53 assessed as increase in early apoptosis at 2 times IC50 after 48 hrs by YoPro/propidium iodide/Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1427344Induction of apoptosis in human HCT116 cells harboring wild-type p53 assessed as upregulation of cyclinB1 measured after 48 hrs by Hoechst staining based assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID361395Cytotoxicity against mouse Hepa-1c1c7 cells2002Journal of natural products, Nov, Volume: 65, Issue:11
Activity-guided isolation of constituents of Renealmia nicolaioides with the potential to induce the phase II enzyme quinone reductase.
AID1427256Cytotoxicity against human Caco2 cells assessed as cell survival at 50 uM after 48 hrs by Hoechst 33342 staining based assay relative to control2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.
AID1537673Cytotoxicity against human REH cells assessed as reduction in cell viability incubated for 72 hrs by alamar blue assay2019MedChemComm, Aug-01, Volume: 10, Issue:8
The winding road of the uvaretin class of natural products: from total synthesis to bioactive agent discovery.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (73)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (15.07)29.6817
2010's54 (73.97)24.3611
2020's8 (10.96)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.99 (24.57)
Research Supply Index4.33 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index30.00 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other72 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]